Design of a Biomaterial using bioluminescence (Nanotheranostic particle or 3D-Scaffold) for the treatment of SARS-Cov-2 infection,...

Design of a Biomaterial using bioluminescence (Nanotheranostic particle or 3D-Scaffold) for the treatment of SARS-Cov-2 infection, which uses monoclonal antibody as a bioactive component for better uptake or adhesion by pulmonary cells.

Expert Solution

Integration of bioluminescent agent enable us to identify the or recognize the cell under specific light for its presence and also treatment of a disease. In such scenario Nanotheranostic particles are the perfect blend of biomaterial for diagnostic and well as therapeutic use through nanotechnology. Similar approach can be used for the detection and treatment of covid 19 (SARS-cov2) patient using monoclonal antibodies tagged with bioluminescent particles as nanoparticle enhance their attachment to the cell and eventually great uptake by the target cell which is lung (pulmonary) cells, We can utilize this approach for the delivery of the drug also. Such approach is being used in personalized medicine also.

gladiator answered 1 year ago

Discuss how our body responds to SARS-Cov-2 infection

COVID-19 is a disease caused by SARS-CoV-2. This coronavirus infection results in an acute respiratory infection...

COVID-19 is a disease caused by SARS-CoV-2. This coronavirus infection results in an acute respiratory infection that can lead to viral pneumonia and end-organ failure. CoV-2 is a RNA virus (single stranded RNA genome) that specifically targets cells in the lungs that express the ACE2 receptor. Answer the three related questions regarding a mucosal immune response to SARS-CoV-2: 1. Which antibody class would you expect to encounter CoV-2 and which T effector T cell would activate B cells? As the...

Other coronaviruses such as SARS-CoV and MERS-CoV are known suppressors of Type I IFNs. Presumably, SARS-CoV-2...

Other coronaviruses such as SARS-CoV and MERS-CoV are known suppressors of Type I IFNs. Presumably, SARS-CoV-2 employs similar strategies. Explain how SARS-CoV and MERS-CoV may interfere with Type I IFN production and signaling through their receptors.

Explain how SARS-COV-2 replicate?

With all that you know about SARS-CoV-2 and Covid-19, discuss a possible evolutionary scenario for SARS-CoV-2...

With all that you know about SARS-CoV-2 and Covid-19, discuss a possible evolutionary scenario for SARS-CoV-2 , over the next 6 months, 1 year and 5 years. How, if at all, will the virulence/trasmissability of SARS-CoV-2 change and why? A vaccine was developed for Polio, but, so far, not for HIV. Will science develop an effective vaccine against SARS-CoV-2? Why or why not?

Using the SARS-CoV-2 tests, explain the processes required for scaling up production of the newer diagnostic...

Using the SARS-CoV-2 tests, explain the processes required for scaling up production of the newer diagnostic testing in a global pandemic and regulatory processes required for use of new diagnostic tests for COVID-19 within Australia, Europe and the United States of America. This section is to describe the some of the manufacturing challenges associated with meeting the rapid demand for tests during emergency or disaster management. Diagnostic tests require regulatory approval by FDA (US), TGA (Australia) and CE (European Union)....

Question

Design of a Biomaterial using bioluminescence (Nanotheranostic particle or 3D-Scaffold) for the treatment of SARS-Cov-2 infection,...

Solutions

Expert Solution

Related Solutions

Discuss how our body responds to SARS-Cov-2 infection

COVID-19 is a disease caused by SARS-CoV-2. This coronavirus infection results in an acute respiratory infection...

Other coronaviruses such as SARS-CoV and MERS-CoV are known suppressors of Type I IFNs. Presumably, SARS-CoV-2...

Explain how SARS-COV-2 replicate?

With all that you know about SARS-CoV-2 and Covid-19, discuss a possible evolutionary scenario for SARS-CoV-2...

Using the SARS-CoV-2 tests, explain the processes required for scaling up production of the newer diagnostic...

Research the Internet (using credible sources). How does SARS-CoV-2 attack our respiratory system?

Policy responses of African States to the SARS-CoV-2 pandemic. Target ( 2 Pages )

The current pandemic is caused by the virus SARS-CoV-2. It is predicted to have an R0...

Define emerging infections using SARS-CoV-2 as an example, which causes the disease COVID-19. Provide an explanation...